Pulsed Levosimendan in advanced heart failure due to congenital heart disease: a case series.

James Cranley Antonia Hardiman Leisa J Freeman

Published in: European heart journal. Case reports (2020)

Intermittent Levosimendan may represent a valuable therapy to reduce hospitalization and improve quality of life in adults with congenital heart conditions.

Keyphrases

congenital heart disease
heart failure
cardiac surgery
acute kidney injury
high intensity
left ventricular
acute heart failure
cardiac resynchronization therapy
mesenchymal stem cells
replacement therapy